Small-cap Biotech Executives Reveal Innovative Technologies at NYSSA Conference
November 22 2010 - 2:56PM
Business Wire
C-level executives from eight biotechnology companies will
discuss their plans to invent, develop, research, and market
important new drugs, diagnostics, and delivery technologies at the
New York Society of Security Analysts’ 14th Annual Biotech and
Specialty Pharma Conference on November 30, 2010. The companies’
developments range from oncology to dermatology therapies.
George Fulop, MD, managing director at Stuyvesant Capital
Management, will discuss the outlook for the biotech and specialty
pharma industry.
After a strong recovery in 2009, investment performance in the
biotech industry is mixed these days, with small-cap companies
generally outperforming the large-cap stocks. The NASDAQ
Biotechnology Index (NBI), the broadest measure of biotech sector
performance, is essentially flat for the year compared to a 1% drop
in the S&P 500. The Amex Biotechnology Index (BTK) is up 18%
for the year. M&A activity is expected to rise in the coming
years due to stunted growth in the big pharma market, which is
projected to hold at 5–8% through 2014 because of drugs that are
coming off patent and will be facing generic competition.
Some of the most innovative small- and micro-cap companies will
present at the conference:
- ADVENTRX Pharmaceuticals, Inc.
(NYSE, AMEX: ANX)
- Anika Therapeutics, Inc. (NASDAQ:
ANIK)
- Cyclacel Pharmaceuticals, Inc.
(NASDAQ: CYCC)
- DARA BioSciences, Inc. (NASDAQ:
DARA)
- EpiCept Corporation (NASDAQ:
EPTC)
- GenSpera, Inc. (OTCBB:
GNSZ)
- Polymedix, Inc. (NYSE:
PYMX)
- Provectus Pharmaceuticals, Inc (OTC:
PVCT)
- Senesco (NYSE, AMEX: SNT)
- SuperGen (NASDAQ: SUPG)
The full-day conference will be held on November 30, 2010 from
8:30 a.m.–4:40 p.m. at 1540 Broadway, Suite 1010, New York, NY
10036.
For more information on the conference, please visit:
www.nyssa.org/biotech.
There is no charge for press with credentials.
About NYSSA
The New York Society of Security Analysts (NYSSA) is a leading
forum for the investment community. NYSSA’s mission is to promote
best practices and the highest professional and ethical standards
in the industry. With over 10,000 members, NYSSA is the largest of
the 135 societies worldwide that make up CFA Institute, which has
more than 100,000 members.
Senesco (AMEX:SNT)
Historical Stock Chart
From Jul 2024 to Aug 2024
Senesco (AMEX:SNT)
Historical Stock Chart
From Aug 2023 to Aug 2024
Real-Time news about Senesco Technologies (American Stock Exchange): 0 recent articles
More News Articles